Home Watchlists Portfolios Indices Forex Futures Market Scan Chart Settings

Reviewing Unum Therapeutics Inc. (UMRX)'s and Atreca Inc. (NASDAQ:BCEL)'s results



  • Source: Stocks Beat - - Read: 0

    Summary:

     

    We are contrasting Unum Therapeutics Inc. (NASDAQ:UMRX) and Atreca Inc. (NASDAQ:BCEL) on their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership. They both are Biotechnology companies, competing one another.

    Valuation and Earnings

    Gross Revenue

    Price/Sales Ratio

    Net Income

    Earnings Per Share

    Price/Earnings Ratio

    Unum Therapeutics Inc.

    3

    4.99

    N/A

    -1.33

    0.00

    Atreca Inc.

    15

    0.00

    N/A

    -1.64

    0.00

    We can see in table 1 the earnings per share, top-line revenue and valuation of Unum Therapeutics Inc. and Atreca Inc.

    Profitability

    Table 2 provides the net margins, return on assets and return on equity of the two firms.

    Net Margins

    Return on Equity

    Return on Assets

    Unum Therapeutics Inc.

    0.00%

    -62.3%

    -43.3%

    Atreca Inc. ...

     

     

    Read Full News: https://stocksbeat.com/2019/08/15/trending-stock-news/reviewing-unum-therapeutics-inc-umrxs-and-atreca-inc-nasdaqbcels-results/


Log in to reply